Dipeptidyl peptidase-4 inhibitor gemigliptin protects against vascular calcification in an experimental chronic kidney disease and vascular smooth muscle cells

Although dipeptidyl peptidase-4 inhibitors, a class of antidiabetic drugs, have various pleiotropic effects, it remains undetermined whether gemigliptin has a beneficial effect on vascular calcification. Therefore, this study was performed to evaluate the effect of gemigliptin on vascular calcificat...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Soon-Youn, Ryu, Hye-Myung, Oh, Eun-Joo, Choi, Ji-Young, Cho, Jang-Hee, Kim, Chan-Duck, Kim, Yong-Lim, Park, Sun-Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5501516/
https://www.ncbi.nlm.nih.gov/pubmed/28686724
http://dx.doi.org/10.1371/journal.pone.0180393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5501516/
https://www.ncbi.nlm.nih.gov/pubmed/28686724
http://dx.doi.org/10.1371/journal.pone.0180393

Ejemplares similares